
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Collagen peptides Type III are bioactive amino acid chains derived from collagen hydrolysis that specifically target skin, blood vessel, and organ structure support. These peptides work by providing glycine, proline, and hydroxyproline to stimulate fibroblast activity and enhance collagen synthesis in tissues rich in Type III collagen.

Reported Benefits (Provisional)
Origin & History

Collagen Peptides (Type III) are derived from the skin and connective tissues of animals, often bovine or marine sources. They are produced through hydrolysis, creating small peptides that are easily absorbed.
Research Narrative (Provisional)
Collagen Peptides (Type III) have been studied for their benefits on skin and connective tissue health, with ongoing research in various applications.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Rich in amino acids like glycine, proline, and alanine. - Contains nutrients essential for skin and connective tissue health. - Easily absorbed and utilized by the body.
Reported Mechanism (Provisional)
Type III collagen peptides deliver specific amino acid sequences including glycine-proline-hydroxyproline triplets that signal fibroblasts to increase collagen production. These peptides activate the mTOR pathway and upregulate collagen gene expression, particularly COL3A1, which codes for Type III collagen synthesis. The peptides also stimulate hyaluronic acid production and enhance cross-linking between collagen fibers in skin and vascular tissues.
Clinical Narrative (Provisional)
Human studies with Type III collagen peptides show 20% improvements in skin hydration and elasticity after 8-12 weeks of supplementation at 2.5-10g daily doses. Randomized controlled trials with 50-120 participants demonstrate significant increases in skin density and reduction in wrinkle depth compared to placebo groups. Evidence for joint and vascular benefits remains preliminary, with most studies focusing on general collagen peptide mixtures rather than isolated Type III peptides. Long-term safety data beyond 24 weeks is currently limited.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







